Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Incidence of pneumococcal disease from 2003 to 2019 in children ≤17 years in England

22 Jan 2023

Abstract excerpt

BACKGROUND: Pneumococcal disease is a leading cause of communicable disease morbidity and mortality globally. We aimed to estimate invasive pneumococcal disease (IPD), pneumococcal pneumonia (PP) and all-cause pneumonia (ACP) incidence rates (IRs) in children aged 0-17 years in England from 2003 to 2019. METHODS: A retrospective study in children ≤17 years old from 2003 to 2019 using the Clinical Practice...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Pneumonia and Respiratory Infections
Share to Respiratory viral infections research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 36683061
DOI: 10.1186/s41479-022-00103-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Incidence of pneumococcal disease from 2003 to 2019 in children ≤17 years in EnglandPMID 36683061Read ↗

Epidemiology of invasive pneumococcal disease in western Sweden during the first 11 years after the introduction of general childhood pneumococcal vaccinationSemantic proximity Read ↗

Parapneumonic effusions related to<i>Streptococcus pneumoniae</i>: serotype and disease severity trends from 2006 to 2018 in Bristol, UKSemantic proximity Read ↗

Streptococcus pneumoniae carriage, serotypes, genotypes, and antimicrobial resistance trends among children in Portugal, after introduction of PCV13 in National Immunization Program: A cross-sectional study.Semantic proximity Read ↗

A model-based evaluation of the cost-effectiveness of paediatric and elderly vaccination against pneumococcal infection in EnglandSemantic proximity Read ↗

Incidence rates, emerging serotypes and genotypes, and antimicrobial susceptibility of pneumococcal disease in Taiwan: A multi-center clinical microbiological study after PCV13 implementation.Semantic proximity Read ↗

Epidemiology Characteristics of Streptococcus pneumoniae From Children With Pneumonia in Shanghai: A Retrospective StudySemantic proximity Read ↗

Risk factors for invasive pneumococcal disease in adults: a systematic review and meta-analysisSemantic proximity Read ↗

Serotype-specific pneumococcal invasiveness: a global meta-analysis of paired estimates of disease incidence and carriage prevalenceSemantic proximity Read ↗

The Impact of Pneumococcal Vaccination on Bacterial and Viral Pneumonia in Western Australian Children: Record Linkage Cohort Study of 469589 Births, 1996–2012Semantic proximity Read ↗

Changes in pneumococcal deaths in the United States following the COVID-19 pandemicSemantic proximity Read ↗

Pneumococcal Meningitis in Adults in 2014-2018 After Introduction of Pediatric 13-valent Pneumococcal Conjugate Vaccine in JapanSemantic proximity Read ↗

Serotype epidemiology and case-fatality risk of invasive pneumococcal disease: a nationwide population study from Switzerland, 2012–2022Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.